A quantitative SVM approach potentially improves the accuracy of magnetic resonance spectroscopy in the preoperative evaluation of the grades of diffuse gliomas
暂无分享,去创建一个
Shaowu Li | Yin Jiang | Yiming Li | Song Yang | Xing Fan | Chong Qi | Rui Wang | Lanxi Meng | Tao Jiang | Yiming Li | T. Jiang | Xing Fan | Shaowu Li | Yin Jiang | Rui Wang | Lanxi Meng | Chong Qi | Y. Jiang | Song Yang
[1] W P Dillon,et al. Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. , 2001, AJNR. American journal of neuroradiology.
[2] Bruce R. Rosen,et al. Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival , 2017, npj Precision Oncology.
[3] A Moreno,et al. Evidence that mobile lipids detected in rat brain glioma by 1H nuclear magnetic resonance correspond to lipid droplets. , 1997, Cancer research.
[4] B. Rosen,et al. Advanced magnetic resonance imaging of the physical processes in human glioblastoma. , 2014, Cancer research.
[5] Ian C. P. Smith,et al. 1H MRS of high grade astrocytomas: Mobile lipid accumulation in necrotic tissue , 1994, NMR in biomedicine.
[6] P. Desmond,et al. Preoperative magnetic resonance spectroscopy improves diagnostic accuracy in a series of neurosurgical dilemmas , 2013, British journal of neurosurgery.
[7] T. Ryken,et al. Can tumor contrast enhancement be used as a criterion for differentiating tumor grades of oligodendrogliomas? , 2005, AJNR. American journal of neuroradiology.
[8] Yu Wang,et al. CGCG clinical practice guidelines for the management of adult diffuse gliomas. , 2016, Cancer letters.
[9] Steven J. M. Jones,et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma , 2016, Cell.
[10] Wenzhen Zhu,et al. Radiomics based on multicontrast MRI can precisely differentiate among glioma subtypes and predict tumour-proliferative behaviour , 2018, European Radiology.
[11] Mitchel S Berger,et al. Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas. , 2007, Journal of neurosurgery.
[12] A. Bjørnerud,et al. Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps. , 2008, Radiology.
[13] Hui Zhang,et al. The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis , 2016, European Radiology.
[14] Patrick Y Wen,et al. Application of Novel Response/Progression Measures for Surgically Delivered Therapies for Gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group , 2012, Neurosurgery.
[15] Jean-Marc Constans,et al. Convex-Envelope Based Automated Quantitative Approach to Multi-Voxel 1H-MRS Applied to Brain Tumor Analysis , 2015, PloS one.
[16] D. Borsook,et al. The role of imaging , 2014, Journal of the peripheral nervous system : JPNS.
[17] Lothar R Schad,et al. Machine learning in preoperative glioma MRI: Survival associations by perfusion‐based support vector machine outperforms traditional MRI , 2014, Journal of magnetic resonance imaging : JMRI.
[18] A. Škoch,et al. Potential of MR spectroscopy for assessment of glioma grading , 2013, Clinical Neurology and Neurosurgery.
[19] Timothy F Cloughesy,et al. Emerging Approaches for Targeting Metabolic Vulnerabilities in Malignant Glioma , 2016, Current Neurology and Neuroscience Reports.
[20] K. Hara,et al. Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. , 1996, AJNR. American journal of neuroradiology.
[21] Yuji Akiyama,et al. Magnetic resonance spectroscopic detection of lactate is predictive of a poor prognosis in patients with diffuse intrinsic pontine glioma. , 2011, Neuro-oncology.
[22] L. Schad,et al. A generic support vector machine model for preoperative glioma survival associations. , 2015, Radiology.
[23] Steven N. Kalkanis,et al. The role of radiotherapy in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline. , 2015 .
[24] Martin R Prince,et al. Immediate Allergic Reactions to Gadolinium-based Contrast Agents: A Systematic Review and Meta-Analysis. , 2018, Radiology.
[25] Steven N. Kalkanis,et al. The role of imaging in the management of adults with diffuse low grade glioma , 2015, Journal of Neuro-Oncology.
[26] Seung Hong Choi,et al. Grading of Cerebral Glioma with Multiparametric MR Imaging and 18F-FDG-PET: Concordance and Accuracy , 2014, European Radiology.
[27] K-H Chang,et al. 3T 1H-MR spectroscopy in grading of cerebral gliomas: comparison of short and intermediate echo time sequences. , 2006, AJNR. American journal of neuroradiology.
[28] F A Howe,et al. The clinical value of proton magnetic resonance spectroscopy in adult brain tumours. , 2007, Clinical radiology.
[29] G. Reifenberger,et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.
[30] Frank G Zöllner,et al. Support vector machines in DSC‐based glioma imaging: Suggestions for optimal characterization , 2010, Magnetic resonance in medicine.
[31] J A Frank,et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. , 1992, Radiology.
[32] Christos Davatzikos,et al. Classification of brain tumor type and grade using MRI texture and shape in a machine learning scheme , 2009, Magnetic resonance in medicine.
[33] Frank G Zoellner,et al. Predictive modeling in glioma grading from MR perfusion images using support vector machines , 2008, Magnetic resonance in medicine.
[34] Corinna Cortes,et al. Support-Vector Networks , 1995, Machine Learning.
[35] Benjamin Haibe-Kains,et al. mRMRe: an R package for parallelized mRMR ensemble feature selection , 2013, Bioinform..